期刊文献+

2012-2013年我院门诊西药房口服心血管类药品用药分析 被引量:3

Analysis of the oral medication for cardiovascular diseases at the outpatient pharmacy in 2012-2013
下载PDF
导出
摘要 目的 :通过分析2012-2013年我院门诊西药房口服心血管系统药物的用药情况,为合理用药和药品监管提供参考。方法 :就上海同济大学附属同济医院2012-2013年口服心血管药品的销售金额及用药频度(DDDs)等进行统计分析。结果:在2012-2013年心血管系统疾病用药中,国产药品和进口药品(含合资)占所有药品的比例呈稳定趋势,心血管药物的DDDs和DDC两项的排名均比较稳定。结论 :我院心血管系统的药物使用频率稳定性好,用药情况基本合理。 Objective: To analyze the oral medication for cardiovascular diseases at the outpatient pharmacy in 2012-2013 so as to provide a reference for the rational use of drug and drug regulation. Methods: The sales and defined daily doses(DDDs) for oral cardiovascular drugs were statistically analyzed. Results: Among the cardiovascular medication, the proportion of both domestic and imported drugs(including joint ventures) to all drugs appears a stable trend and the ranks of DDDs and DDC of cardiovascular drugs were relatively stable. Conclusion: DDDs for cardiovascular diseases are stable with a basically rational use of drug in our hospital.
作者 陈蓓蕾
出处 《上海医药》 CAS 2015年第5期54-55,65,共3页 Shanghai Medical & Pharmaceutical Journal
关键词 口服心血管系统药物 用药频度 用药分析 cardiovascular medication DDDs analysis on medication usage
  • 相关文献

参考文献2

二级参考文献14

  • 1刘力生,王文,姚崇华.2009年基层版《中国高血压防治指南》(摘录)[J].中国医学前沿杂志(电子版),2010,2(1):60-74. 被引量:74
  • 2Wang W, Ma L, Zhang Y, et al. The combination of amlodipine and angiotensin receptor blocker or diuretics in high-risk hypertensive patients:rationale,design and baseline characteristics[J]..J Hum Hypertens, 2011, 25(4): 271-277.
  • 3Mancia G, Paratia G, Biloa G, et al. Blood pressure controlbythe- nifedipine GITS-telmisartan combination in patients at highcardiovascular risk:the TALENT study[J]. J Hypertens, 2011, 29(3): 600-609.
  • 4Wang JG, Kario K, Lau T, et al. Use of dihydropyridine calcium channel blockers in the management of hypertension in Eastern Asians:a scientific statement from the Asian Pacific heartassociation[J]. Hypertens Res, 2011, 34(4): 423-430.
  • 5Elliott HL, Meredith PA. Preferential benefits of nifedipine GITS in systolic hypertension and in combination with RAS blockade: urther analysis of the "ACTION" database in patients with angina[J]. J Hum Hypertens, 2011, 25(1): 63-70.
  • 6ONTARGET Investigators, Yusuf S, Teo KK, et al.Telmisartan,ramipril.or both in patients at high risk for vascular events[J]. N Engl J Med, 2008, 358(15): 1547-1559.
  • 7Geng DF, Jin DM, Wu W, et al. Angiotensin receptor blockersfor prevention of new-onset type 2 diabetes: a meta- analysis of 59862 patients[J]. Int J Cardiol, 2012, 155(2): 236- 242.
  • 8胡大一.高血压的立体化管理[J].中国医学导刊,2013,15(91:1373-1374.
  • 9王文,马丽媛,刘明波,邓卿,张宇清,李卫,朱鼎良,林曙光,黄峻,刘力生.初始低剂量氨氯地平加替米沙坦或复方阿米洛利联合治疗对高血压患者血压控制率影响的阶段报告[J].中华心血管病杂志,2009,37(8):701-707. 被引量:87
  • 10刘力生.中国高血压防治指南2010[J].中华高血压杂志,2011,19(8):701-708. 被引量:6936

共引文献8

同被引文献21

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部